ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

RLYB Rallybio Holdings LLC

1,57
-0,01 (-0,63%)
Vor Marktöffnung
Zuletzt aktualisiert: 12:45:16
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Rallybio Holdings LLC RLYB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,63% 1,57 12:45:16
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,58
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
21.5.202422:22EDGAR2Form 8-K - Current report
21.5.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
17.5.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.5.202422:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09.5.202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202414:11EDGAR2Form 8-K - Current report
09.5.202414:00BWRallybio Reports First Quarter 2024 Financial Results and..
07.5.202414:00BWRallybio to Present at the 2024 Citizens JMP Life Sciences..
17.4.202422:01BWFNAIT Systematic Literature Review and Meta-Analysis..
10.4.202422:01BWRallybio Announces Collaboration to Advance Therapeutic..
01.4.202416:05BWRallybio Announces FNAIT Systematic Literature Review to be..
12.3.202413:00BWRallybio Reports Fourth Quarter and Full Year 2023 Financial..
26.2.202414:00BWRallybio to Present at the TD Cowen 44th Annual Health Care..
17.2.202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202414:15EDGAR2Form 8-K - Current report
06.2.202414:00BWRallybio Announces Portfolio Prioritization and Provides..
04.1.202414:00BWRallybio Highlights Portfolio Advances and Outlines Expected..
20.12.202314:15EDGAR2Form 8-K - Current report
20.12.202314:00BWRallybio Announces Preliminary Phase 1 Multiple Ascending..
09.12.202318:00BWRallybio Presents Natural History Study for Fetal and..
28.11.202313:00BWRallybio Announces Preliminary Multiple Dose Data from the..
09.11.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:10EDGAR2Form 8-K - Current report
09.11.202314:00BWRallybio Reports Third Quarter 2023 Financial Results and..
08.11.202314:00BWRallybio to Present at Upcoming Investor Conferences in..
02.11.202314:15BWRallybio Announces Acceptance of FNAIT Natural History Study..
03.10.202314:00BWRallybio to Present at the JonesTrading 2023 Healthcare..
03.9.202318:00BWRallybio Presents Phase 1 Single Ascending Dose Data for..
31.8.202314:00BWRallybio to Present at Upcoming Investor Conferences in..
08.8.202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202314:16EDGAR2Form 8-K - Current report
08.8.202314:00BWRallybio Reports Second Quarter 2023 Financial Results and..
02.8.202314:00BWRallybio to Present at the 2023 Wedbush PacGrow Healthcare..
11.7.202314:00BWRallybio Announces Acceptance of Abstract for RLYB116 at the..
29.6.202313:30EDGAR2Form 8-K - Current report
29.6.202313:00BWRallybio Announces Succession Plan; Appoints Stephen Uden,..
24.6.202321:30BW Rallybio Announces Proof-of-Concept Results and Development..
09.6.202315:15BWRallybio to Present Data from the RLYB212 Phase 1b..
01.6.202314:00BWRallybio to Present at the Jefferies Healthcare Conference

Kürzlich von Ihnen besucht

Delayed Upgrade Clock